Altay Therapeutics

About:

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.

Website: https://www.altaytherapeutics.com/

Top Investors: Y Combinator, Bossanova Investimentos, Creative Destruction Lab (CDL), Tachyon Ventures, Erik Peterson

Description:

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It was founded in 2019 and is headquartered in San Francisco, California.

Total Funding Amount:

$3.24M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)altaytherapeutics.com

Founders:

Ali Ozes, Osman Nidai Ozes

Number of Employees:

1-10

Last Funding Date:

2022-09-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai